- NLM Digital Collections - Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer : effectiveness and value : ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017... patients with two or more prior lines of platinum-based chemotherapy who were in complete or partial response to ... are in a complete or partial response to platinum-based chemotherapy Rucaparib Monotherapy for patients with 600 mg BID ( ...
- NLM Digital Collections - Indication-specific pricing of pharmaceuticals in the United States health care system : a ...Publication: Boston, MA : Institute for Clinical and Economic Review, March 2016... or anthracyclines is not appropriate In addition to platinum-based chemotherapy, indicated for first-line treatment of adult patients ... therapy for locally advanced disease - in combination with platinum-based chemotherapy for recurrent and/ or metastatic disease Dose In ...
- NLM Digital Collections - Management of epithelial ovarian cancer : a national clinical guidelinePublication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), 2013... three trials indicated that women who received adjuvant platinum based chemotherapy had better overall survival than those who did ... of surgical staging. The authors concluded that adjuvant platinum based chemotherapy is effective in prolonging the survival of the ...
- NLM Digital Collections - Management of adult testicular germ cell tumours : a national clinical guidelinePublication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), March 2011... information for patients who relapse after first line platinum based chemotherapy. 4 2 KEY RECOMMENDATIONS 2.6 late toxicity ... information for patients who relapse after first line platinum based chemotherapy. 27 Management of Adult Testicular Germ Cell Tumours ...
- NLM Digital Collections - Management of lung cancer : a national clinical guidelinePublication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), February 2014... patients whose disease has not progressed immediately following platinum based chemotherapy. In a full submission, the manufacturer did not ... 2000;27(3):145-57. previously treated with platinum-based chemotherapy. J Clin Oncol 2000;18(10):2095-103. ...
- NLM Digital Collections - Drugs against cancer : stories of discovery and the quest for a curePublication: Bethesda, Maryland : National Cancer Institute, [2022]... cancer drugs. Kelland, L. (2007). The resurgence of platinum-based cancer chemotherapy. Nature reviews Cancer 7, 573-584. 98 K. ... Jordheim, L.P. (2021). Enhancing the activity of platinum-based drugs by ... repair. Cancer chemotherapy and pharmacology 87, 259-267. Cleaver, J.E. ( ...
- NLM Digital Collections - Strengthening the accelerated approval pathway : an analysis of potential policy reforms and ....Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 26, 2021... improvements in OS among patients previously treated with platinum-based therapy who were subsequently treated with atezolizumab, as compared with chemotherapy. However, atezolizumab did appear to be better tolerated ...
- NLM Digital Collections - Novel agents to prevent chemotherapy-induced neutropenia and other myelosuppressive effects : ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 17, 2022... EGFR-wild type (wt) progressing on a prior platinum-based regimen. Annals of Oncology. 2021;32:81326. 34, Roberts PJ, Kumarasamy V, Witkiewicz AK, Knudsen ES. Chemotherapy and CDK4/6 Inhibitors: Unexpected Bedfellows. Mol Cancer ...
8 results